0

Lupus Erythematosus Collection
 1-20 of 248 Articles
Updates |  17 July 2012
Update in Rheumatology: Evidence Published in 2011
Lindsy J. Forbess, MD; Anne R. Bass, MD
Ann Intern Med. 2012;157(2):114-119. doi:10.7326/0003-4819-157-2-201204030-00408
Editorials |  21 June 2005
Help for Menopausal Patients with Lupus?
Evelyn V. Hess, MD
Ann Intern Med. 2005;142(12_Part_1):1014-1015. doi:10.7326/0003-4819-142-12_Part_1-200506210-00011
Articles |  21 June 2005
The Effect of Combined Estrogen and Progesterone Hormone Replacement Therapy on Disease Activity in Systemic Lupus Erythematosus: A Randomized Trial
Jill P. Buyon, MD; Michelle A. Petri, MD, MPH; Mimi Y. Kim, ScD; et al.
Ann Intern Med. 2005;142(12_Part_1):953-962. doi:10.7326/0003-4819-142-12_Part_1-200506210-00004
Editorials |  21 August 2001
The Treatment of Lupus Nephritis: Revisiting Galen
Edmund J. Lewis, MD
Ann Intern Med. 2001;135(4):296-298. doi:10.7326/0003-4819-135-4-200108210-00014
Articles |  21 August 2001
Combination Therapy with Pulse Cyclophosphamide plus Pulse Methylprednisolone Improves Long-Term Renal Outcome without Adding Toxicity in Patients with Lupus Nephritis
Gabor G. Illei, MD; Howard A. Austin, MD; Marianna Crane, NP; et al.
Ann Intern Med. 2001;135(4):248-257. doi:10.7326/0003-4819-135-4-200108210-00009
Brief Communications |  18 April 2000
Potentiation of Vitamin K Antagonists by High-Dose Intravenous Methylprednisolone
Nathalie Costedoat-Chalumeau, MD; Zahir Amoura, MD; Guy Aymard, PhD; et al.
Ann Intern Med. 2000;132(8):631-635. doi:10.7326/0003-4819-132-8-200004180-00005
Currents |  15 December 1998
New Approaches for Treatment of Systemic Lupus Erythematosus
Philip M. Bulman; Gene Hunder, MD, MS
Ann Intern Med. 1998;129(12):1095-1096. doi:10.7326/0003-4819-129-12-199812150-00051
Articles |  15 January 1998
The Pathophysiologic Roles of Interleukin-6 in Human Disease
Dimitris A. Papanicolaou, MD; Ronald L. Wilder, MD, PhD; Stavros C. Manolagas, MD, PhD; et al.
Ann Intern Med. 1998;128(2):127-137. doi:10.7326/0003-4819-128-2-199801150-00009
Articles |  1 August 1997
Monitoring Warfarin Therapy in Patients with Lupus Anticoagulants
Stephan Moll, MD; Thomas L. Ortel, MD, PhD
Ann Intern Med. 1997;127(3):177-185. doi:10.7326/0003-4819-127-3-199708010-00001
Editorials |  15 January 1997
DNA and the Immune System
David S. Pisetsky, MD, PhD
Ann Intern Med. 1997;126(2):169-171. doi:10.7326/0003-4819-126-2-199701150-00015
Articles |  1 October 1996
Methylprednisolone and Cyclophosphamide, Alone or in Combination, in Patients with Lupus Nephritis: A Randomized, Controlled Trial
Mark F. Gourley, MD; Howard A. Austin III, MD; Dorothy Scott, MD; et al.
Ann Intern Med. 1996;125(7):549-557. doi:10.7326/0003-4819-125-7-199610010-00003
Reviews |  1 July 1995
Systemic Lupus Erythematosus: Emerging Concepts: Part 2: Dermatologic and Joint Disease, the Antiphospholipid Antibody Syndrome, Pregnancy and Hormonal Therapy, Morbidity and Mortality, and Pathogenesis
Dimitrios T. Boumpas, MD; Barri J. Fessler, MD; Howard A. Austin III, MD; et al.
Ann Intern Med. 1995;123(1):42-53. doi:10.7326/0003-4819-123-1-199507010-00007
Reviews |  15 June 1995
Systemic Lupus Erythematosus: Emerging Concepts: Part 1: Renal, Neuropsychiatric, Cardiovascular, Pulmonary, and Hematologic Disease
Dimitrios T. Boumpas, MD; Howard A. Austin, MD; Barri J. Fessler, MD; et al.
Ann Intern Med. 1995;122(12):940-950. doi:10.7326/0003-4819-122-12-199506150-00009
Brief Communications |  15 March 1995
Postmenopausal Estrogen Therapy and the Risk for Developing Systemic Lupus Erythematosus
Jorge Sanchez-Guerrero, MD, MSc; Matthew H. Liang, MD, MPH; Elizabeth W. Karlson, MD; et al.
Ann Intern Med. 1995;122(6):430-433. doi:10.7326/0003-4819-122-6-199503150-00005
Articles |  15 March 1994
Antiphospholipid Antibodies in Predicting Adverse Pregnancy Outcome: A Prospective Study
Anne Lynch, MB; Richard Marlar, PhD; James Murphy, PhD; et al.
Ann Intern Med. 1994;120(6):470-475. doi:10.7326/0003-4819-120-6-199403150-00004
Articles |  15 October 1993
Reliability of Histologic Scoring for Lupus Nephritis: A Community-based Evaluation
Richard M. Wernick, MD; David L. Smith, MD; Donald C. Houghton, MD; et al.
Ann Intern Med. 1993;119(8):805-811. doi:10.7326/0003-4819-119-8-199310150-00006
Articles |  1 September 1993
Risk for Sustained Amenorrhea in Patients with Systemic Lupus Erythematosus Receiving Intermittent Pulse Cyclophosphamide Therapy
Dimitrios T. Boumpas, MD; Howard A. Austin, MD; Ellen M. Vaughan, RN; et al.
Ann Intern Med. 1993;119(5):366-369. doi:10.7326/0003-4819-119-5-199309010-00003
Editorials |  1 July 1993
Superantigens and Microbial Pathogenesis
Dennis D. Taub, PhD; Kenneth J. Blank, PhD
Ann Intern Med. 1993;119(1):89-90. doi:10.7326/0003-4819-119-1-199307010-00016
Articles |  15 August 1992
Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients
Michael H. Rosove, MD; Petronella M. C. Brewer, RN
Ann Intern Med. 1992;117(4):303-308. doi:10.7326/0003-4819-117-4-303
Articles |  15 January 1992
Progression and Remission of Renal Disease in the Lupus Nephritis Collaborative Study: Results of Treatment with Prednisone and Short-term Oral Cyclophosphamide
Andrew S. Levey, MD; Shu-Ping Lan, MPH; Howard L. Corwin, MD; et al.
Ann Intern Med. 1992;116(2):114-123. doi:10.7326/0003-4819-116-2-114
Advertisement

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)